EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis – Medscape
- EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis Medscape
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 October 2025 European Medicines Agency
- Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Yahoo Finance
- EU regulator backs first-ever treatment for bronchiectasis Investing.com
- Insmed Incorporated CHMP Recommends EU Approval of Brinsupri (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis MarketScreener